Bioter
Bioter (BIOT) closed at €0.206 on 05/11/2026, +0.00% on the day. Market cap €3.3m.
Announcements to the exchange
BIOT +0.0% (€0.206 → €0.206) · General Index —
Deepest fall inside it: none, it never closed below an earlier close
Drag across the chart to measure any stretchSlide sideways across the chart to measure
Key statistics
12 months to Jun 2026 unless a figure says otherwise
Profile
At the 5 Nov close- Market value
- Enterprise valueJun 2026est.
- Shares outstandingJun 2026
- Revenue12 months to Jun 2026
- Employees
- Free floatest.
- Traded a day, 3-month average
Valuation
12 months to Jun 2026- P/E
- —
- EV/Salesest.
- P/FCFFY2024
- —
- Dividend yield
not meaningful: a loss
not meaningful here
Margins
12 months to Jun 2026- GrossFY2025
- —
- EBITDA
- —
- Operating (EBIT)
- —
- Pre-taxFY2025
- —
- Net
- —
- Free cash flowFY2024under review
its accounts show no gross profit
not meaningful here
not meaningful here
not meaningful here
not meaningful here
Returns
12 months to Jun 2026- ROCE
- ROICest.
- ROAFY2025
- Tax rateFY2025
Financial health
Jun 2026- CashDec 2025
- Net debt
- Interest cover12 months to Jun 2026
- —
not meaningful: finance items were a net income
finance items were a net income
Growth
- Revenue, last yearFY2025
- Revenue, last halfH1 2026
- —
- EPS, last yearFY2025
- —
- EPS, last halfH1 2026
- Revenue, 3 yearsFY2022–25, a year
- Revenue, 5 yearsFY2020–25, a year
- EPS, 3 yearsFY2022–25, a year
- —
- Shares, 3 yearsFY2022–25est.
not meaningful here
not meaningful: from a loss
not meaningful: crosses a loss
Dividends
FY2025- Yield, last 12 months
- Per share
- —
- Payout
- —
- Covered by free cash flow
- —
- Years paid, last fiveFY2021–25
not meaningful here
nothing paid in 12 months
not meaningful here
Trading and risk
From our closes, dividends reinvested- Total return, 1 year
- +0.0%
- 3 years, a year
- −0.6%
- 5 years, a year
- −10.0%
- Volatility, 1 year
- 0.0%
- Beta to the General Index
- 0.12×
- Deepest fall, 1 year / 5 years
- 0.0% / −68.3%
- 52-week range
- €0.206–€0.206
Where the figures come from: the company's reports, reviewed by us · annual accounts filed in ESEF format · results announcements on the exchange · our own closing prices. No forecasts or target prices are stored.
Financial charts
From the stored figures: the reviewed dossier first, then the annual reports (ESEF) and results announcements
Loading the charts…
Valuation
3 companies| Metric | BIOT | Peer median | Peer range |
|---|---|---|---|
| P/E | — | 11.8 | 11.6 12.1 |
| P/B | — | 2.5 | 2.2 3.7 |
| P/S | 7.8 | 1.2 | 1.1 1.4 |
| EV/EBITDA | — | 6.8 | 6.6 7.0 |
| Dividend yield | 0.0% | 0.0% | 0.0% 1.8% |
| Payout ratio | — | 0.0% | 0.0% 18.9% |
| Operating margin | — | 14.3% | 13.4% 15.2% |
| Net margin | — | 10.4% | 9.1% 11.6% |
| ROE | — | 24.4% | 18.4% 30.3% |
| Revenue growth (last full year) | −69.0% | 15.6% | 10.8% 81.9% |
| Net debt | €127.8m | −€1.6m | -€7.3m €6m |
Peers: Construction
The company
AI-draftedShares suspended since 2 June 2025. The exchange decided in December 2025 to delete them, then extended their stay in suspension, to 31 December 2026 according to the company. A four-person Greek contractor, it is selling property and restructuring its debt. Group equity was −€93.4m at 30 June 2026; the company estimates +€15.6m at 30 September.
- Oct 2026The company estimates group equity of +€15.6m at 30 September 2026 after the new agreement's write-offs.10
- Aug 2026The new restructuring agreement of 31 July 2026 was filed for court ratification.8
- Jul 2026Stay in suspension extended to 31 December 2026, as the company reports.2,9
- Jun 2026Nominal value cut to €0.30 and a cash increase of up to €2.0m approved; three Moschato plots sold for €5.109m.6,7
- Dec 2025The exchange decided to delete the shares, with removal set for 22 January 2026.1,5
- Jun 2025Trading in the share suspended from 2 June.4
- Suspended from 2 June 2025 after more than two years in the Surveillance category; deletion decided on 19 December 2025, extended to 2 June 2026 and, per the company, to 31 December 2026.1,2,4
- The FY2025 auditor flags a material uncertainty on going concern; equity is negative.1
- FY2025 profit of €54.4m came from an interest write-off; H1 2026 property sales lost €10.8m.1,2
- The new restructuring agreement of 31 July 2026 awaits court ratification; the company estimates equity of +€15.6m at 30 September 2026.8,10
- 1.FY2025 annual reportBIOTER S.A. · 29/04/2026official
- 2.H1 2026 interim reportBIOTER S.A. · 30/09/2026official
- 3.Issuer pageEuronext Athensofficial
- 4.Suspension noticeBIOTER S.A. · 30/05/2025official
- 5.Deletion decision noticeBIOTER S.A. · 24/12/2025official
- 6.EGM decisionsBIOTER S.A. · 24/06/2026official
- 7.Plot sale noticeBIOTER S.A. · 30/06/2026official
- 8.New restructuring agreement noticeBIOTER S.A. · 06/08/2026official
- 9.AGM decisionsBIOTER S.A. · 28/08/2026official
- 10.Estimated equity noticeBIOTER S.A. · 09/10/2026official